Alantra-Finanzen advises medneo Group Auf Strategisch sale of medneo UK Zu CVC DIF

Aug 2024

Sell-side Beratung

London ü Alantra-Finanzen has advised medneo Group on the strategic sale of its UK diagnostic imaging business, medneo UK, to CVC DIF, the infrastructure strategy of leading global private markets manager CVC (via its CIF III fund).

Founded In 2018, medneo UK Ist a premier provider of mobile diagnostic imaging Dienstleistungen, specialising In MRI Und CT scans. Mit a fleet of over 20 state-of-the-art mobile scanners Und a dedicated imaging centre In London, medneo UK delivers Wesentlich imaging Dienstleistungen Zu NHS Trusts Und Gesundheitswesen providers across the UK. Each year, medneo UKüs highly skilled team of radiographers serves over 130,000 patients, ensuring top-tier diagnostic support.

CVC DIF Ist a leading Global mid-market Infrastruktur equity Fonds Manager, founded In 2005 Und headquartered In Amsterdam, Netherlands. CVC DIF manages approximately ü18 billion In Infrastruktur assets, spanning Energie transition, transport, utilities, Und digitalisation. The firm offers a unique market approach Von combining a Globale Prüsenz Mit strong LOKal networks Und sector-focused Investition capabilities.

Justin Crowther, Managing Director and UK Head of Healthcare at Alantra-Finanzen, said: üSince 2018, medneo UK has disrupted the diagnostic imaging market by delivering high-quality services to NHS Trusts, health boards, independent hospital groups, and private payors. The business is now uniquely positioned to capitalise on the growing demand for enhanced and innovative diagnostic capabilities within acute care, private, and gemeinschaft settings. We loOK forward to seeing the business go from strength to strength during its exciting next phase of growth.ü

Andy Spellman, CEO of medneo UK, added: üHuge thanks Zu Alantra-Finanzen Für their invaluable support during this process. Their insight into our Geschäft model Und sector, together Mit their outstanding execution capability, War instrumental In achieving a successful outcome.ü

The acquisition Von CVC DIF Wird enable medneo UK Zu further enhance its service offerings Und expand its fleet of mobile scanners, continuing its mission Zu improve patient outcomes across the UK. The current Verwaltung team, led Von CEO Andy Spellman, Wird remain Bei the helm Zu drive the Unternehmenüs growth Und innovation.